- May 28th, 2016
- Brit Long
- leave a comment
- categories:
Pulmonary embolism (PE) is a disease process associated with significant morbidity and mortality. The benefits of thrombolytics for massive PE has been established in the literature. But what does the evidence say about the use of thrombolytics for submassive PE? What are the current guidelines and recommendations? As emergency physicians how should we apply the current evidence for the use of thrombolytics in submassive PE?